These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25706839)

  • 1. What are affordable vaccines?
    Lancet; 2015 Jan; 385(9965):304. PubMed ID: 25706839
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintaining the vaccine safety net.
    Hannan C; Buchanan AD; Monroe J
    Pediatrics; 2009 Dec; 124 Suppl 5():S571-2. PubMed ID: 19948593
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving access to vaccines through tiered pricing.
    Berkley S
    Lancet; 2014 Jun; 383(9936):2265-7. PubMed ID: 24636625
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valuing childhood vaccines.
    Schlenker T
    J Pediatr; 2004 Oct; 145(4):568; author reply 568. PubMed ID: 15480391
    [No Abstract]   [Full Text] [Related]  

  • 6. Valuing childhood vaccines.
    Davis MM; Kemper AR
    J Pediatr; 2003 Sep; 143(3):283-4. PubMed ID: 14517503
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemophilus influenzae type b diseases in Asia.
    Lau YL
    Bull World Health Organ; 1999; 77(11):867-8. PubMed ID: 10612880
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing vaccine-preventable diseases in low-resource communities.
    Rodewald LE; Markowitz LE
    Arch Pediatr Adolesc Med; 2009 May; 163(5):487-8. PubMed ID: 19414699
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting research and a case for optimism.
    Gates B
    Sci Transl Med; 2013 Dec; 5(214):214ed21. PubMed ID: 24307689
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry perspectives: ensuring vaccination of children and adolescents without financial barriers.
    Feinberg MB; Gordon L
    Pediatrics; 2009 Dec; 124 Suppl 5():S563-4. PubMed ID: 19948589
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine finance resources for physicians.
    Sobczyk E
    Pediatrics; 2009 Dec; 124 Suppl 5():S573-6. PubMed ID: 19948594
    [No Abstract]   [Full Text] [Related]  

  • 12. Are high prices a barrier to human papillomavirus vaccination in the United States? Not in Italy.
    Garattini L; van de Vooren K
    JAMA Pediatr; 2014 Jun; 168(6):584. PubMed ID: 24886804
    [No Abstract]   [Full Text] [Related]  

  • 13. Price transparency is a step towards sustainable access in middle income countries.
    Cernuschi T; Gilchrist S; Hajizada A; Malhame M; Mariat S; Widmyer G
    BMJ; 2020 Jan; 368():l5375. PubMed ID: 31932333
    [No Abstract]   [Full Text] [Related]  

  • 14. Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine.
    Kharbanda EO; Lee GM; Koenigs L;
    J Adolesc Health; 2011 Mar; 48(3):320-1. PubMed ID: 21338909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing financial barriers to vaccination in the United States: call to action.
    Birkhead GS; Orenstein WA; Almquist JR
    Pediatrics; 2009 Dec; 124 Suppl 5():S451-4. PubMed ID: 19948574
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 17. Financing of vaccines.
    Barton JH
    Lancet; 2000 Apr; 355(9211):1269-70. PubMed ID: 10770320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination in the United States: payer perspective on the working group and its recommendations.
    Rosenberg AB
    Pediatrics; 2009 Dec; 124 Suppl 5():S565-6. PubMed ID: 19948590
    [No Abstract]   [Full Text] [Related]  

  • 19. Africa could learn from India's burgeoning pharma sector.
    Selvaraj S
    BMJ; 2013 Aug; 347():f4235. PubMed ID: 23913693
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction of new and underutilized vaccines: sustaining access, disease control, and infrastructure development.
    Andrus JK; Fitzsimmons J
    PLoS Med; 2005 Oct; 2(10):e286. PubMed ID: 16156693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.